AAVogen (United States)

Recent papers from AAVogen (United States)

1. Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseasesGene Therapy · 2025
2. Development and validation of a model gene therapy biodistribution assay for AVGN7 using digital droplet polymerase chain reactionMolecular Therapy — Methods & Clinical Development · 2023
3. Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.2022
4. Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating DrugsEndocrine Reviews · 2021
5. Demembranated skeletal and cardiac fibers produce less force with altered cross-bridge kinetics in a mouse model for limb-girdle muscular dystrophy 2iAJP Cell Physiology · 2019
6. Myostatin regulates pituitary development and hepatic IGF1AJP Endocrinology and Metabolism · 2019
7. Systemic SMAD7 Gene Therapy Increases Striated Muscle Mass and Enhances Exercise Capacity in a Dose-Dependent MannerHuman Gene Therapy · 2017